CACNB2

Chr 10AD

calcium voltage-gated channel auxiliary subunit beta 2

Also known as: CAB2, CACNLB2, CAVB2, MYSB

This gene encodes a beta subunit of voltage-dependent calcium channels that increases peak calcium current and modulates channel activation and inactivation, particularly contributing to beta-adrenergic regulation of heart rate and contractile force in cardiomyocytes. Mutations cause Brugada syndrome 4, a cardiac arrhythmia disorder with autosomal dominant inheritance. The gene is highly constrained against loss-of-function variants (pLI nearly 1.0), indicating that complete loss of function is likely incompatible with survival.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

Brugada syndrome 4MIM #611876
AD
0
Active trials
15
Pubs (1 yr)
4
P/LP submissions
0%
P/LP missense
0.69
LOEUF
DN
Mechanism· predicted
Clinical SummaryCACNB2
🧬
Gene-Disease Validity (ClinGen)
cardiogenetic disease · ADDisputed

Disputed — evidence questions this relationship

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
4 unique Pathogenic / Likely Pathogenic· 281 VUS of 500 total submissions
📖
GeneReview available — CACNB2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.69LOEUF
pLI 0.000
Z-score 2.95
OE 0.45 (0.300.69)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.07Z-score
OE missense 0.99 (0.911.08)
390 obs / 393.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.45 (0.300.69)
00.351.4
Missense OE0.99 (0.911.08)
00.61.4
Synonymous OE1.24
01.21.6
LoF obs/exp: 15 / 33.4Missense obs/exp: 390 / 393.7Syn Z: -2.22
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedCACNB2-related hypertrophic cardiomyopathyOTHERAD
limitedCACNB2-related short QT syndromeOTHERAD
limitedCACNB2-related Brugada syndromeOTHERAD
DN
0.7230th %ile
GOF
0.5955th %ile
LOF
0.51top 25%

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

500 submitted variants in ClinVar

Classification Summary

Pathogenic3
Likely Pathogenic1
VUS281
Likely Benign196
Benign2
Conflicting1
3
Pathogenic
1
Likely Pathogenic
281
VUS
196
Likely Benign
2
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
3
0
3
Likely Pathogenic
1
0
0
0
1
VUS
9
239
30
3
281
Likely Benign
2
5
70
119
196
Benign
0
0
2
0
2
Conflicting
1
Total12244105122484

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CACNB2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →